2010
DOI: 10.1186/1472-6874-10-5
|View full text |Cite
|
Sign up to set email alerts
|

Preconception care of women with diabetes: a review of current guideline recommendations

Abstract: BackgroundThe prevalence of type 2 diabetes mellitus (T2DM) continues to rise worldwide. More women from developing countries who are in the reproductive age group have diabetes resulting in more pregnancies complicated by T2DM, and placing both mother and foetus at higher risk. Management of these risks is best achieved through comprehensive preconception care and glycaemic control, both prior to, and during pregnancy. The aim of this review was to compare the quality and content of current guidelines concern… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
46
0
6

Year Published

2010
2010
2021
2021

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 59 publications
(53 citation statements)
references
References 30 publications
1
46
0
6
Order By: Relevance
“…Despite this, many did not actually recommend using contraception or delaying pregnancy until optimal control was achieved. Diabetes preconception guidelines internationally are consistent in counselling about ensuring adequate contraception until glycaemic control is achieved, but differences in recommended preconception HbA1c targets may contribute to clinical uncertainty [37]. Contributors to a lack of counselling for delaying pregnancy in this circumstance may be the complexity of care and cross-cultural communication difficulties as well as health providers not wishing to be overly negative or authoritarian.…”
Section: Discussionmentioning
confidence: 99%
“…Despite this, many did not actually recommend using contraception or delaying pregnancy until optimal control was achieved. Diabetes preconception guidelines internationally are consistent in counselling about ensuring adequate contraception until glycaemic control is achieved, but differences in recommended preconception HbA1c targets may contribute to clinical uncertainty [37]. Contributors to a lack of counselling for delaying pregnancy in this circumstance may be the complexity of care and cross-cultural communication difficulties as well as health providers not wishing to be overly negative or authoritarian.…”
Section: Discussionmentioning
confidence: 99%
“…Severe birth defects occur when blood glucose is and has been high. Therefore, a hemoglobin A1C greater than 10% is considered a contraindication to pregnancy [3], meaning that pregnancy is not recommended because the risk of birth defects is too high.…”
Section: 3 Hemoglobin A1cmentioning
confidence: 99%
“…However, glyburide and metformin have been promising in clinical studies and are often used, especially in women who were using these medications prior to pregnancy. Since the safety profiles of other medications are not well known, it is important to modify medication regimens prior to pregnancy to allow for both good control of blood sugar and safety to the developing fetus [3].…”
Section: 3 Hemoglobin A1cmentioning
confidence: 99%
“…Optimizing maternal and fetal outcomes is best done with preconception planning for all types of diabetes in pregnancy. In pregestational diabetes, women who know they have T1DM or T2DM should achieve and sustain glycemic control before conception to minimize their risk of fetal malformation (2)(3)(4)(5). Organogenesis is essentially completed by 7 weeks gestation, often before the woman knows she is pregnant.…”
Section: Pregestational Diabetesmentioning
confidence: 99%
“…2 Pregestational diabetes includes both type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM).…”
mentioning
confidence: 99%